Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Clear Cell Renal Cell Carcinoma”

708 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 708 results

Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Testing effectiveness (Phase 2)Study completedNCT03463681
What this trial is testing

CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Early research (Phase 1)Ended earlyNCT00492440
What this trial is testing

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Cytheris SA 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04393350
What this trial is testing

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Kidney CancerStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
Emory University 18
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05363631
What this trial is testing

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Who this might be right for
Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
Mohammed Milhem 55
Large-scale testing (Phase 3)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 1,116
Not applicableStudy completedNCT03744585
What this trial is testing

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

Who this might be right for
Renal Cell Carcinoma
Ipsen 450
Early research (Phase 1)Active Not RecruitingNCT05891171
What this trial is testing

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Who this might be right for
Advanced CancerAdvanced MalignanciesBladder Cancer+9 more
Arcus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783348
What this trial is testing

Radiopharmaceutical Treatment of Advanced Kidney Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Early research (Phase 1)Ended earlyNCT00520533
What this trial is testing

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Ludwig Institute for Cancer Research 8
Early research (Phase 1)Study completedNCT02835833
What this trial is testing

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaColorectal AdenocarcinomaNon-squamous Non-small Cell Lung Cancer+2 more
University of Alabama at Birmingham 21
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT00017329
What this trial is testing

PS-341 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT02072044
What this trial is testing

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Who this might be right for
Renal Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Early research (Phase 1)Study completedNCT02219711
What this trial is testing

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 193
Large-scale testing (Phase 3)Study completedNCT00492986
What this trial is testing

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 1,150
Load More Results